These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1231 related items for PubMed ID: 9856074

  • 21. Enhancement of osteoblast proliferation in vitro by selective enrichment of demineralized freeze-dried bone allograft with specific growth factors.
    Mott DA, Mailhot J, Cuenin MF, Sharawy M, Borke J.
    J Oral Implantol; 2002; 28(2):57-66. PubMed ID: 12498447
    [Abstract] [Full Text] [Related]

  • 22. Effect of PDGF, IL-1alpha, and BMP2/4 on corneal fibroblast chemotaxis: expression of the platelet-derived growth factor system in the cornea.
    Kim WJ, Mohan RR, Mohan RR, Wilson SE.
    Invest Ophthalmol Vis Sci; 1999 Jun; 40(7):1364-72. PubMed ID: 10359318
    [Abstract] [Full Text] [Related]

  • 23. Transforming growth factor-beta 1 (TGF-beta1) prevents the age-dependent decrease in bone formation in human osteoblast/implant cultures.
    Zhang H, Aronow MS, Gronowicz GA.
    J Biomed Mater Res A; 2005 Oct 01; 75(1):98-105. PubMed ID: 16044414
    [Abstract] [Full Text] [Related]

  • 24. Systemic administration of transforming growth factor-beta 2 prevents the impaired bone formation and osteopenia induced by unloading in rats.
    Machwate M, Zerath E, Holy X, Hott M, Godet D, Lomri A, Marie PJ.
    J Clin Invest; 1995 Sep 01; 96(3):1245-53. PubMed ID: 7657798
    [Abstract] [Full Text] [Related]

  • 25. [Periodontal regeneration: the use of polypeptide growth factors].
    Di Genio M, Barone A, Ramaglia L, Sbordone L.
    Minerva Stomatol; 1994 Oct 01; 43(10):437-43. PubMed ID: 7700221
    [Abstract] [Full Text] [Related]

  • 26. [Effects of bone morphogenetic protein and transforming growth fractor-beta on biomechanical property for fracture healing in rabbit ulna].
    He XB, Lu WZ, Tang KL, Yang L, He J, Zhu QH, Liu XD, Xu JZ.
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2003 May 01; 17(3):185-8. PubMed ID: 12822345
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Recombinant human transforming growth factor beta 1 modulates bone remodeling in a mineralizing bone organ culture.
    Chen TL, Bates RL.
    J Bone Miner Res; 1993 Apr 01; 8(4):423-34. PubMed ID: 8475792
    [Abstract] [Full Text] [Related]

  • 32. Alteration of the chemotactic response of human skin fibroblasts to PDGF by growth factors.
    Soma Y, Takehara K, Ishibashi Y.
    Exp Cell Res; 1994 Jun 01; 212(2):274-7. PubMed ID: 8187819
    [Abstract] [Full Text] [Related]

  • 33. Effects on glycosaminoglycan synthesis in cultured human mesothelioma cells of transforming, epidermal, and fibroblast growth factors and their combinations with platelet-derived growth factor.
    Tzanakakis GN, Karamanos NK, Hjerpe A.
    Exp Cell Res; 1995 Sep 01; 220(1):130-7. PubMed ID: 7664829
    [Abstract] [Full Text] [Related]

  • 34. Relative binding and biochemical effects of heterodimeric and homodimeric isoforms of platelet-derived growth factor in osteoblast-enriched cultures from fetal rat bone.
    Centrella M, McCarthy TL, Kusmik WF, Canalis E.
    J Cell Physiol; 1991 Jun 01; 147(3):420-6. PubMed ID: 2066362
    [Abstract] [Full Text] [Related]

  • 35. Transforming growth factor-beta enhances fracture healing in rabbit tibiae.
    Lind M, Schumacker B, Søballe K, Keller J, Melsen F, Bünger C.
    Acta Orthop Scand; 1993 Oct 01; 64(5):553-6. PubMed ID: 8237323
    [Abstract] [Full Text] [Related]

  • 36. Effect of recombinant human transforming growth factor-beta2 dose on bone formation in rat femur titanium implant model.
    Sena K, Sumner DR, Virdi AS.
    J Biomed Mater Res A; 2010 Mar 01; 92(3):1210-7. PubMed ID: 19322883
    [Abstract] [Full Text] [Related]

  • 37. Additive enhancement of implant fixation following combined treatment with rhTGF-beta2 and rhBMP-2 in a canine model.
    Sumner DR, Turner TM, Urban RM, Virdi AS, Inoue N.
    J Bone Joint Surg Am; 2006 Apr 01; 88(4):806-17. PubMed ID: 16595471
    [Abstract] [Full Text] [Related]

  • 38. Osteogenic actions of phenytoin in human bone cells are mediated in part by TGF-beta 1.
    Nakade O, Baylink DJ, Lau KH.
    J Bone Miner Res; 1996 Dec 01; 11(12):1880-8. PubMed ID: 8970889
    [Abstract] [Full Text] [Related]

  • 39. Osseointegration on metallic implant surfaces: effects of microgeometry and growth factor treatment.
    Frenkel SR, Simon J, Alexander H, Dennis M, Ricci JL.
    J Biomed Mater Res; 2002 Dec 01; 63(6):706-13. PubMed ID: 12418014
    [Abstract] [Full Text] [Related]

  • 40. Local application of rhTGF-beta2 enhances peri-implant bone volume and bone-implant contact in a rat model.
    De Ranieri A, Virdi AS, Kuroda S, Shott S, Leven RM, Hallab NJ, Sumner DR.
    Bone; 2005 Jul 01; 37(1):55-62. PubMed ID: 15869922
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 62.